Mr. ZHOU Fanghang (周方行)

Research Output

  1. 2020
  2. Accepted/In press/Filed

    PIM1 Inhibitors for Use in Treatment of Viral Infection and Pharmaceutical Compositions Thereof

    CHEN, Y., HE, M., WAN, Q. & ZHOU, F., 30 Apr 2020, (Accepted/In press/Filed) Priority No. PCT/CN2020/088009

    Research output: Patents, Agreements and Assignments (RGC: 51, 52, 53)51_Patents granted (CityU only, data source from KTO)

    Check@CityULib
  3. 2019
  4. Published

    Pim1 Impacts Enterovirus A71 Replication and Represents a Potential Target in Antiviral Therapy

    Zhou, F., Wan, Q., Lu, J., Chen, Y., Lu, G. & He, M. L., 27 Sep 2019, In : iScience. 19, p. 715-727

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journal

    Scopus citations: 2
    Check@CityULib
  5. Accepted/In press/Filed

    Methods of Treatment of Viral Infection and Uses of Pim1 Inhibitors

    CHEN, Y., HE, M., WAN, Q. & ZHOU, F., 30 Apr 2019, (Accepted/In press/Filed) Priority No. 62/840,819

    Research output: Patents, Agreements and Assignments (RGC: 51, 52, 53)51_Patents granted (CityU only, data source from KTO)

    Check@CityULib
  6. 2018
  7. Accepted/In press/Filed

    一種多肽及其應用

    CHEN, Y., HE, M. & ZHOU, F., 27 Jun 2018, (Accepted/In press/Filed) Priority No. 201810678621.3

    Research output: Patents, Agreements and Assignments (RGC: 51, 52, 53)51_Patents granted (CityU only, data source from KTO)

    Check@CityULib
  8. Published

    Novel HDAC5-interacting motifs of Tbx3 are essential for the suppression of E-cadherin expression and for the promotion of metastasis in hepatocellular carcinoma

    Dong, L., Dong, Q., Chen, Y., Li, Y., Zhang, B., Zhou, F., Lyu, X. & 4 others, Chen, G. G., Lai, P., Kung, H. & He, M., 2018, In : Signal Transduction and Targeted Therapy. 3, 22.

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journal

    Scopus citations: 10
    Check@CityULib